comprehensive -WSS

comprehensive

author：fashion 2025-10-02 10:45:49 - browse：544

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

knowledge

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Decaf coffee targeted by food safety group under obscure FDA rule

Primary care physicians play key roles in Alzheimer's management

Vertex Pharmaceuticals may move headquarters in Boston

Eliminate the waiting period for sterilization covered by Medicaid

Readout LOUD podcast: mifepristone case, GLP

hotspot

comprehensive

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Roche subsidiary Foundation Medicine opens new headquarters

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Oprah kicked off a national conversation on obesity. Let's have it

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Moonlake's readout produced a cash windfall. Risks remain

Patient advocates debate FDA's accelerated approval process

Anesthesiologist group: stop taking Ozempic before surgery

Scientists boost immune system in aging mice by making it youthful

entertainment

Decaf coffee targeted by food safety group under obscure FDA rule

Primary care physicians play key roles in Alzheimer's management

Steward Health Care has deal to sell doctor network to UnitedHealth

Decaf coffee targeted by food safety group under obscure FDA rule

Abortion pill case raises question: who can sue the FDA?

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

focus

knowledge

explore